BioCentury | Oct 22, 2020
Politics, Policy & Law

Protecting biomedical innovation as a national security asset

...a senior executive of Cephalon Inc. and US Oncology Inc....
BioCentury | Jun 3, 2019
Clinical News

Following promising ASCO readout for AMG 510, Amgen looks to identify more KRAS-mutant patients

...to participate in clinical trials of candidates from Amgen's pipeline. The initiative's first partners are US Oncology...
BioCentury | Mar 13, 2017
Company News

FDA approves Novartis' Kisqali

...the pharma expects a decision next half. On a conference call Monday, Head of Novartis US Oncology...
BioCentury | Jul 14, 2015
Company News

Management tracks

...commercial officer, a newly created position. Bogle was EVP of strategy and emerging businesses at US Oncology Inc....
BioCentury | Sep 12, 2011
Finance

Sacrifice the Bishop

...as EVP and general counsel. Most recently, Osborn was general counsel for oncology services company US Oncology Inc....
BioCentury | Sep 5, 2011
Company News

Dendreon management update

...John Osborn as EVP, general counsel and corporate secretary, formerly EVP and general counsel of US Oncology Inc....
BioCentury | Sep 1, 2011
Company News

Dendreon names Osborn EVP, general counsel

...EVP, general counsel and corporate secretary. He is the former EVP and general counsel of US Oncology Inc....
BioCentury | Jul 11, 2011
Regulation

Rashomon effect

...a medical breast oncologist at Baylor Charles A. Sammons Cancer Center , Texas Oncology and US Oncology...
...Texas UnitedHealthcare Group (NYSE:UNH), Minnetonka, Minn. U.S. Food and Drug Administration (FDA), Silver Spring, Md. US Oncology...
BioCentury | Jan 10, 2011
Company News

McKesson Corp., US Oncology deal

...previously announced acquisition of US Oncology. The companies said the deal, which includes the assumption of US Oncology's...
...valued at $2.2 billion (see BioCentury, Nov. 8, 2010). McKesson Corp. (NYSE:MCK), San Francisco, Calif. US Oncology Inc....
BioCentury | Nov 8, 2010
Company News

McKesson Corp., US Oncology deal

...Healthcare services and information technology company McKesson will acquire oncology services company US Oncology to expand its...
...presence in the oncology market. The companies said the deal, which includes the assumption of US Oncology's...
...March 31, 2011, and slightly accretive beginning in FY12. McKesson Corp. (NYSE:MCK), San Francisco, Calif. US Oncology Inc....
Items per page:
1 - 10 of 17
BioCentury | Oct 22, 2020
Politics, Policy & Law

Protecting biomedical innovation as a national security asset

...a senior executive of Cephalon Inc. and US Oncology Inc....
BioCentury | Jun 3, 2019
Clinical News

Following promising ASCO readout for AMG 510, Amgen looks to identify more KRAS-mutant patients

...to participate in clinical trials of candidates from Amgen's pipeline. The initiative's first partners are US Oncology...
BioCentury | Mar 13, 2017
Company News

FDA approves Novartis' Kisqali

...the pharma expects a decision next half. On a conference call Monday, Head of Novartis US Oncology...
BioCentury | Jul 14, 2015
Company News

Management tracks

...commercial officer, a newly created position. Bogle was EVP of strategy and emerging businesses at US Oncology Inc....
BioCentury | Sep 12, 2011
Finance

Sacrifice the Bishop

...as EVP and general counsel. Most recently, Osborn was general counsel for oncology services company US Oncology Inc....
BioCentury | Sep 5, 2011
Company News

Dendreon management update

...John Osborn as EVP, general counsel and corporate secretary, formerly EVP and general counsel of US Oncology Inc....
BioCentury | Sep 1, 2011
Company News

Dendreon names Osborn EVP, general counsel

...EVP, general counsel and corporate secretary. He is the former EVP and general counsel of US Oncology Inc....
BioCentury | Jul 11, 2011
Regulation

Rashomon effect

...a medical breast oncologist at Baylor Charles A. Sammons Cancer Center , Texas Oncology and US Oncology...
...Texas UnitedHealthcare Group (NYSE:UNH), Minnetonka, Minn. U.S. Food and Drug Administration (FDA), Silver Spring, Md. US Oncology...
BioCentury | Jan 10, 2011
Company News

McKesson Corp., US Oncology deal

...previously announced acquisition of US Oncology. The companies said the deal, which includes the assumption of US Oncology's...
...valued at $2.2 billion (see BioCentury, Nov. 8, 2010). McKesson Corp. (NYSE:MCK), San Francisco, Calif. US Oncology Inc....
BioCentury | Nov 8, 2010
Company News

McKesson Corp., US Oncology deal

...Healthcare services and information technology company McKesson will acquire oncology services company US Oncology to expand its...
...presence in the oncology market. The companies said the deal, which includes the assumption of US Oncology's...
...March 31, 2011, and slightly accretive beginning in FY12. McKesson Corp. (NYSE:MCK), San Francisco, Calif. US Oncology Inc....
Items per page:
1 - 10 of 17